Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc를 보는 글로벌 시선
이 종목 직접 발언을 우선한 글로벌 증권사·투자대가의 공개 원문 · RICHMAP 추천 아님
재무 요약
Finnhub /stock/metric · 연간 기준 · 캐시 6h▸ Finnhub /stock/profile2 · 캐시 24h · 모든 수치 API 원값 (RICHMAP 가공·추정 없음)
관련 뉴스
Finnhub /company-news · 최근 14일 · 캐시 30minLabcorp Stock Jumps 14% in a Month as Growth Meets Rich Valuation
LH shares surged 14% in a month as stronger earnings, margin gains and growth collide with a valuation above the company's five-year median.
원문 보기 ↗ Yahoo[Latest] Global gRNA Market Size/Share Worth USD 2950 Million by 2034 at a 19% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global gRNA Market size & share revenue was valued at approximately USD 518 …
원문 보기 ↗ YahooBecton Dickinson Lifts Full-Year Profit Outlook as Third-Quarter Results Top Views
Becton Dickinson (BDX) raised its full-year earnings guidance as the medical device maker's third-qu
원문 보기 ↗ Yahoo[Latest] Global Deep Eutectic Solvents Market Size/Share Worth USD 735.89 Million by 2034 at a 15.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Deep Eutectic Solvents Market size & share revenue was valued at appr…
원문 보기 ↗ YahooWeak Growth In Its Primary Market Continues To Weigh Heavily On Bruker Shares
Bruker Corporation faces ongoing headwinds from weak academic/government funding that has compressed growth. Read more on BRKR stock here.
원문 보기 ↗ SeekingAlpha3 Cash-Producing Stocks We Think Twice About
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
원문 보기 ↗ YahooThermo Fisher Raises 2026 Outlook After Strong Second-Quarter Results
TMO lifted its 2026 outlook after Q2 topped estimates, driven by stronger demand, acquisitions and margin gains. Can the momentum continue?
원문 보기 ↗ YahooUnlocking Thermo Fisher (TMO) International Revenues: Trends, Surprises, and Prospects
Examine the evolution of Thermo Fisher's (TMO) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
원문 보기 ↗ YahooTop Analyst Reports for Microsoft, Palo Alto Networks & American Express
Microsoft rides AI, Copilot and Azure growth, but can expanding cloud demand and capacity challenges shape its next phase?
원문 보기 ↗ YahooAnalysts Appear Bullish on Thermo Fisher (TMO): Is The Stock Really a Buy After Earnings?
Thermo Fisher Scientific Inc. (NYSE:TMO) recently announced strong fiscal Q2 2026 results, with revenue growing 10% to $11.99 billion, GAAP diluted EPS rising 9% to $4.68, and adjusted EPS growing 13%…
원문 보기 ↗ YahooHow Thermo Fisher Is Riding Bioproduction and AI-Led Growth Trends
TMO is expanding bioproduction, AI tools and clinical data capabilities, but execution will be key as competition intensifies.
원문 보기 ↗ YahooThermo Fisher Scientific (TMO) Could Be 2% Undervalued After Q2 Earnings Beat
Thermo Fisher Scientific (TMO) is back in focus after reporting second quarter results that exceeded market expectations, supported by broad-based demand and fresh regulatory clearances across its dia…
원문 보기 ↗ Yahoo내 성향 트레이더로 도전
주어는 당신의 성향이지 이 종목이 아닙니다. 6시간부터 1년까지 운용기간을 고르면, AI가 기간에 맞는 주기로 가상 매매합니다. 페이지를 닫아도 서버에서 계속 진행됩니다.
트레이더 성향 설정
객관식만 · 주관식 0 · 생성 후 변경 불가
본 페이지는 정보 제공 목적의 종목 정보 색인이며, 투자 권유·자문·중개가 아닙니다. RICHMAP은 증권사·금융투자업자가 아닙니다. 시세·재무·뉴스는 외부 데이터 소스(Finnhub 등)의 정보로 실시간성·정확성을 보증하지 않습니다. 모든 수치는 API 원값으로 RICHMAP의 가공·추정이 없으며, 조회 실패 시 "데이터 없음"으로 명시됩니다. 투자 판단과 그 결과 책임은 본인에게 있으며, 실제 거래는 정식 인가 증권사를 통해 본인 판단하에 진행하시기 바랍니다.